Banks Healthcare Sector

Andlauer Healthcare Group

Market Cap: CA$2.1b

A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.

Edgewise Therapeutics

Market Cap: US$1.5b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Janux Therapeutics

Market Cap: US$1.5b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

Phreesia

Market Cap: US$1.5b

Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

ARS Pharmaceuticals

Market Cap: US$1.5b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

GoodRx Holdings

Market Cap: US$1.5b

Offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

Ryman Healthcare

Market Cap: NZ$2.4b

Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly people in New Zealand and Australia.

Indivior

Market Cap: UK£1.1b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Travere Therapeutics

Market Cap: US$1.4b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Mesoblast

Market Cap: AU$2.2b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Adaptive Biotechnologies

Market Cap: US$1.4b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Omnicell

Market Cap: US$1.4b

Provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.

89bio

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Tandem Diabetes Care

Market Cap: US$1.4b

Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

Structure Therapeutics

Market Cap: US$1.4b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

SS Innovations International

Market Cap: US$1.4b

Operates as a commercial-stage surgical robotics company in India and internationally.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

Neogen

Market Cap: US$1.3b

Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.

Liquidia

Market Cap: US$1.3b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Dyne Therapeutics

Market Cap: US$1.3b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Celldex Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Heska

Market Cap: US$1.3b

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.

MannKind

Market Cap: US$1.3b

A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.

dentalcorp Holdings

Market Cap: CA$1.8b

Through its subsidiaries, provides health care services by acquiring and partnering with dental practices in Canada.

Azenta

Market Cap: US$1.3b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Green Thumb Industries

Market Cap: CA$1.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Artivion

Market Cap: US$1.2b

Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Astrana Health

Market Cap: US$1.2b

A healthcare management company, provides medical care services in the United States.

Teladoc Health

Market Cap: US$1.2b

Provides virtual healthcare services worldwide.

AdaptHealth

Market Cap: US$1.2b

Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

Sienna Senior Living

Market Cap: CA$1.7b

Provides senior living services in Canada.

Vera Therapeutics

Market Cap: US$1.2b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Innoviva

Market Cap: US$1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

CVS Group

Market Cap: UK£886.7m

Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.